MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Hepion Pharmaceuticals, Inc. (HEPA)

Hepion Pharmaceuticals, Inc. (HEPA)

|||

Balance Sheets Overview

Current Ratio
391.15%
Quick Ratio
391.15%
Debt to Asset Ratio
33.67%
Unit: Dollar
Assets Breakdown
    • Cash
    • Prepaid expenses
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Convertible preferred stock-Seri...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash
1,628,625
2,602,580
1,828,062
2,321,078
Prepaid expenses
298,817
102,923
1,241,890
1,419,162
Total current assets
1,927,442
2,705,503
3,069,952
3,740,240
Total assets
1,927,442
2,705,503
3,069,952
3,740,240
Accounts payable
169,875
138,442
167,810
77,243
Accrued expenses
322,884
347,130
77,507
55,859
Notes payable, current
-
-
54,066
214,309
Subscription liability
-
250,000
-
-
Total current liabilities
492,759
735,572
299,383
347,411
Derivative financial instrumentswarrants
156,164
113,175
103,022
68,397
Total liabilities
648,923
848,747
402,405
415,808
Convertible preferred stock-Series APreferred Stock
855,808
855,808
855,808
855,808
Convertible preferred stock-Series CPreferred Stock
839,320
839,320
839,320
839,320
Common stock0.0001 par value per share 120,000,000 shares authorized, 29,120,317 and 11,620,317 issued and outstanding at june 30, 2026 and december 31, 2025, respectively
2,912
1,162
1,162
1,162
Additional paid-in capital
247,728,818
247,060,568
247,060,568
247,060,568
Accumulated other comprehensive income
8,345
8,345
8,345
8,345
Accumulated deficit
-248,156,684
-246,908,447
-246,097,656
-245,440,771
Total stockholders equity
1,278,519
1,856,756
2,667,547
3,324,432
Total liabilities and stockholders equity
1,927,442
2,705,503
3,069,952
3,740,240
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash$1,628,625 (-44.31%↓ Y/Y)Prepaid expenses$298,817 (-81.10%↓ Y/Y)Total current assets$1,927,442 (-57.22%↓ Y/Y)Total assets$1,927,442 (-57.22%↓ Y/Y)Total liabilities andstockholders equity$1,927,442 (-57.22%↓ Y/Y)Total stockholdersequity$1,278,519 (-66.33%↓ Y/Y)Total liabilities$648,923 (-8.41%↓ Y/Y)Accumulated deficit-$248,156,684 (-1.30%↓ Y/Y)Additional paid-in capital$247,728,818 (0.27%↑ Y/Y)Total currentliabilities$492,759 (-16.88%↓ Y/Y)Derivative financialinstrumentswarrants$156,164 (35.00%↑ Y/Y)Convertible preferredstock-Series APreferred...$855,808 (0.00%↑ Y/Y)Convertible preferredstock-Series CPreferred...$839,320 (0.00%↑ Y/Y)Accumulated othercomprehensive income$8,345 (0.00%↑ Y/Y)Common stock0.0001 parvalue per share...$2,912 (150.60%↑ Y/Y)Accrued expenses$322,884 (565.81%↑ Y/Y)Accounts payable$169,875 (-1.63%↓ Y/Y)